Patient info

Naltrexone Hydrochloride 50 mg film-coated tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
50 mg
Contains active substance:
ATC code:

Patient leaflet - Naltrexone Hydrochloride 50 mg film-coated tablets

1. What Naltrexone hydrochloride is and what it is used for

Naltrexone hydrochloride is used as part of a treatment programme to help you stop taking opiates and remain off of them.

Naltrexone belongs to a group of medicines called opiate antagonists. It blocks the euphoric feelings (highs) that you may experience after taking opiates. In treatment for withdrawal from opiates it will reduce the craving.

Naltrexone tablets do not cause dependency.

2. What you need to know before you take Naltrexone hydrochloride

Do not take Naltrexone hydrochloride if:

  • you are allergic to naltrexone hydrochloride or any of the other ingredients of this medicine (listed in section 6)
  • you have severe liver problems or acute hepatitis
  • you have severe kidney problems
  • you are taking opioid-containing drugs
  • you are taking methadone
  • you are opioid-addicted (without successful withdrawal)
  • you experience acute symptoms of opioid withdrawal
  • you experience withdrawal symptoms after a naloxone injection or your urine tests positive for opiates.

Warnings and precautions

Your treatment should be started by a physician experienced in treatment of addictions.

  • Don’t take opiates whilst taking Naltrexone tablets. Although Naltrexone will normally block some of the effects (i.e. the highs), if you take high doses of opiates, you may experience breathing difficulties and problems with your circulation (opiate poisoning).
  • You should not use Naltrexone if you are still addicted to opiates as Naltrexone will cause severe withdrawal symptoms in this situation.
  • You must inform every doctor that treats you that you are taking Naltrexone. Non-opiate based anaesthetics should be used if you require an anaesthetic in an emergency situation. If you have to use opiate containing anaesthetics, you may need higher doses than usual. You may also be more sensitive to the side-effects (breathing difficulties and circulatory problems).
  • You must not try to overcome the blocking effect of Naltrexone with high doses of opiates. There is a risk that the opiates could still be in your body after the effects of Naltrexone have passed. If this occurs, you could unintentionally overdose with serious consequences.
  • Naltrexone is removed from the body by the liver and kidney. Liver problems are common in opiate-dependant individuals. You doctor will carry out liver function tests before and during treatment.

Other medicines and Naltrexone hydrochloride

Tell your doctor if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.

Some common medicines contain opiates and these may not work when you are taking Naltrexone hydrochloride. You should inform your doctor if you need cough-mixtures or medicines against diarrhoea or pain since these may contain opiates.

If, despite the contraindication to use in

conjunction, opioid containing drugs are needed in emergency cases the suitable dose for pain relief can be higher as usual. Close monitoring through the doctor is absolutely necessary because occurring respiratory depression and other symptoms may be stronger and longer-lasting.

Naltrexone hydrochloride with food and drink

Food and drink do not interfere with the effects of Naltrexone.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Naltrexone hydrochloride should only be used in pregnancy if the benefit to the mother is greater than the possible risk.

Breastfeeding is not recommended if you are taking Naltrexone hydrochloride.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Naltrexone hydrochloride may make you feel less alert or drowsy. You should not drive or operate machines if you are affected. Naltrexone hydrochloride contains lactose

Naltrexone hydrochloride contains lactose (a kind of sugar). If you have ever been told that you have intolerance to some sugars, contact your doctor before taking this medicine.

3. How to take Naltrexone hydrochloride Use in adults

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

The initial dose of Naltrexone hydrochloride is half a tablet (25 mg) on the first day of treatment. After that the usual dose is one tablet per day (50 mg). Your doctor may prescribe a different dosage depending on your individual needs.

The amount of time you should take Naltrexone hydrochloride for will be decided by your doctor. The usual length of treatment is three months. However, in certain cases, a longer period of treatment may be beneficial.

Use in children and adolescents

Naltrexone hydrochloride should not be used in children and adolescents under 18 years. Use in elderly

There are insufficient data on the safety and efficacy for this indication in elderly patients. If you take more Naltrexone hydrochloride than you should

If you take more Naltrexone hydrochloride than you should, tell your Doctor or Pharmacist or contact your nearest hospital emergency department immediately.

If you forget to take Naltrexone hydrochloride

Do not take a double dose to make up for a forgotten dose. Never take more than your prescribed dose at one time.

If you stop taking Naltrexone hydrochloride

After stopping treatment with Naltrexone hydrochloride you may be more sensitive to the effects of opiates. You could unintentionally overdose, even if you take the same dose as you previously used. This is because you build up tolerance whilst taking opiates and once you stop, this tolerance is lost. If you take a high dose, this could have severe consequences or Package leaflet: Information for the user Naltrexone hydrochloride 50 mg film-coated tablets

(Naltrexone hydrochloride)

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you get any of the side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet:
  • What Naltrexone hydrochloride is and what it is used for
  • What you need to know before you take Naltrexone hydrochloride
  • How to take Naltrexone hydrochloride
  • Possible side effects
  • How to store Naltrexone hydrochloride
  • country release

    technical release

Naltrexone hydrochloride 50 mg 28 f-tbl. (UK) NTXT26

Temmler Pharma GmbH

Member of the Aenova Group

PIL, page 1/2

14.08.2025: new WR layout

ref.no:

BP4NTHTALFGB50/28/02/25/1 Format: 160 x 400 mm

max. 10 Pt

line spacing: 11 Pt

RELEASE name, company, date, signature in extreme cases may even be fatal.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. The most serious side effects occurring in people taking Naltrexone hydrochloride include feeling depressed, feeling suicidal, attempted suicide and hallucinations. Although these effects are rare or uncommon, if you do experience any of these, then you must contact you Doctor or Pharmacist immediately for help and support.

The following side effects to Naltrexone hydrochloride are sorted according to their frequency:

Very common (may affect more than 1 in 10 patients)

Anxiety, sleeplessness, headache, restlessness, nervousness, abdominal pain, nausea, vomiting, joint and muscle pain, weakness

Common (may affect up to 1 in 10 patients) Decreased appetite, heart palpitations, increased heart rate, anomalies in ECG, libido disorders, thirst, dizziness, increased tear secretion, chest pains, diarrhoea, constipation, rash, delayed ejaculation, erectile dysfunction, increased energy, irritability, increased sweating, affective disorders

Uncommon (may affect up to 1 in 100 patients) Oral herpes, athlete’s foot, enlarged lymph nodes, hallucination, confusion, depression, paranoia, disorientation, nightmares, agitation, abnormal dreams, shaking, drowsiness, vision disorders, irritation and swelling of the eye, photophobia, eye pain or tiredness, eye strain, blood pressure changes, hot flushes, nasal congestion, nasal discomfort, rhinorrhoea (runny nose), sneezing, disorders of the mouth and throat, increased sputum, sinus disorders, disorders of the voice, coughing, breathlessness, yawning, flatulence, haemorrhoids, ulcer, mouth dryness, hepatic disorders, increased bilirubin levels, hepatitis, seborrhea (mild dermatitis), acne, hair loss, itching, groin pain, abnormally frequent urination, painful urination, tinnitus, vertigo, ear pain, ear discomfort, increased appetite, weight loss, weight gain, fever, pain, sensation of cold in extremities

Rare (may affect up to 1 in 1,000 patients) Decreased number of blood platelets, thoughts of suicide, attempted suicide

Very rare (may affect up to 1 in 10,000 patients) Breakdown of skeletal muscle tissue Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via

Yellow Card Scheme,

Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Naltrexone hydrochloride

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after “Exp”. The expiry date refers to the last day of that month.

Do not store above 25 °C. Store in the original package in order to protect from moisture. If you notice any defects in the tablets such as chipped or broken tablets, ask your pharmacist for advice before taking them.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Naltrexone hydrochloride contains

Each tablet contains 50 mg of the active substance naltrexone hydrochloride. The other ingredients are:

Lactose monohydrate, powdered cellulose, microcrystalline cellulose, silica colloidal anhydrous, crospovidone, magnesium stearate, hypromellose, titanium dioxide (E 171),

macrogol 4000, black ferric oxide (E172), red ferric oxide (E 172), yellow ferric oxide (E 172). What Naltrexone hydrochloride looks like and contents of the pack

Naltrexone hydrochloride film-coated tablets are beige and capsule-shaped, with a break-line across the middle. The film-coated tablet can be divided in to equal halves.

Naltrexone hydrochloride is available in packs of 7, 14, 28, 30 and 56 tablets.

Not all pack sizes may be marketed. Marketing Authorisation Holder

Walter Ritter GmbH + Co. KG

Spaldingstraße 110 B

20097 Hamburg

Germany

Manufacturer

Walter Ritter GmbH + Co. KG

Brüder-Grimm-Straße 121

36396 Steinau an der Straße

Germany

This medicinal product is authorised in the Member States of the EEA and United Kingdom (Northern Ireland) under the following names:

Czech Republic Naltrexone Walter Ritter 50 mg potahované tablety Denmark Naltrexon Walter Ritter filmovertrukne tabletter Germany Naltrexon HCl Walter Ritter 50 mg Filmtabletten Ireland Naltrexone 50 mg film-coated tablets

Netherlands Naltrexon HCl Walter Ritter 50 mg, filmomhulde tabletten Slovenia Naltrekson Walter Ritter 50 mg filmsko obložene tablet United Kingdom Naltrexone hydrochloride 50 mg (Northern Ireland) film-coated tablet

The leaflet was last revised in August 2025.

BP4NTHTALFGB50/ 28/02/25/1

51760389

country release

technical release

Naltrexone hydrochloride 50 mg 28 f-tbl. (UK) NTXT26

PIL, page 2/2

14.08.2025: new WR layout

RELEASE name, company, date, signature

Temmler Pharma GmbH

Member of the Aenova Group

ref.no:

max. 10 Pt line spacing: 11 Pt

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 40311/0002

Last revision stated in the text: August 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Naltrexone Hydrochloride 50 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Naltrexone
Strength 50 mg
Pharmaceutical form Oral tablet
Yellow coloured, oval, biconvex, film coated tablets with breakline on one side and plain on other side.
The tablet can be divided into equal doses.
How is it taken Oral
Excipients Lactose monohydrate, Cellulose Microcrystalline, Crospovidone, Colloidal anhydrous silica, Magnesium stearate, Hypromellose (E464), Macrogol 400, Polysorbate 80 (E 433), Iron Oxide Yellow (E172), Iron oxide red (E172), Titanium Dioxide (E171)
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 2 years
Storage This medicinal product does not require any special storage conditions
Drug group (ATC) Other nervous system drugs; drugs used in addictive disorders, drugs used in alcohol dependence
  1. N Nervous system drugs
    1. N07 Other nervous system drugs
      1. N07B Drugs used in addictive disorders
        1. N07BB Drugs used in alcohol dependence
          1. N07BB04 naltrexone
Marketing authorisation PL 20075/0144 (first authorised 1 March 2010), PL 40311/0002
Marketing authorisation holder Accord Healthcare Limited
Codes GTIN 5060149314258 · BNF 04100300

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.